RxDoctor Payments Data

Edserie Munoz

Adult Health · Orlando, FLNPI 1437704947

Payments from drug & device makers

$1,923in general payments, 2019–2025

Across 66 payments — averaging $29.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$617
  • Braintree Laboratories, Inc.$232
  • Lucid Diagnostics Inc.$140
  • Sanofi$137
  • Takeda Pharmaceuticals U.S.A., Inc.$122
  • Johnson & Johnson$117
  • plus $559 from 19 others

What the payments were for

  • Food & beverage$1,83896%
  • Education$854%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,923 in reported general payments places this provider in the 75th percentile of 2,237 adult health providers in Florida.

See all adult health providers in Florida

Medicare billing

Part B allowed, 2024
$29,731
Medicare patients
168
Services billed
264

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
CreonLipase/Protease/Amylase12$41,193
LinzessLinaclotide24$12,693
Dexlansoprazole DrDexlansoprazole21$7,205
Famotidine285$4,538
Colestipol Hcl28$2,891
Pantoprazole Sodium250$2,220
Sucralfate51$1,417
Omeprazole71$1,271
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl77$1,201
Dicyclomine Hcl35$701
Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl17$287
Hydrocortisone13$227
Metronidazole11$124
Ondansetron Hcl14$86

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieCreon, Linzess$617$53,88636 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,237 adult health providers in Florida.

Other adult health in Orlando

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →